GGrantIndex
Sort

27,075 grants matching cholesterol

Southern California Research Center for ALPD and Cirrhosis

$1,476,617
Hidekazu Tsukamoto · University Of Southern California · P50 · FY2013 · AA

What Does Health Insurance Do? Evidence from the Oregon Health Insurance Lottery

$1,476,236
Katherine Baicker · National Bureau Of Economic Research · R01 · FY2014 · AG

Determining Cardiovascular Health Using High-Throughput Comparative Proteomics

$1,475,837
Stephen Naylor · Predictive Physiology And Medicine, Inc. · R44 · FY2008 · HL

Saturated Fat and Protein Effects on Atherogenic Dyslipidemia

$1,475,328
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · R01 · FY2014 · HL

Investigating mammalian innate immune responses to pathogenic fungi

$1,471,736
Eric Dang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

The Mechanisms of Alterations in Sleep with Age

$1,471,357
Allan Ian Pack · University Of Pennsylvania · P01 · FY2009 · AG

SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT

$1,471,114
Alan R Kimmel · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

The Wake Forest Center for Botanical Lipids and Inflammatory Disease Prevention

$1,469,927
Floyd H Chilton · Wake Forest University Health Sciences · P50 · FY2011 · AT

Lipidomics and structural genomics of cardiometabolic health in Samoan adults

$1,466,436
Ryan Lee Minster · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL

Functional Analysis of Novel Genes in Eye Development and Vision

$1,464,469
Graeme J Wistow · National Eye Institute · ZIA · FY2024 · EY

Statins as Adjunctive, Host-Directed Therapy for TB

$1,463,317
Petros C Karakousis · Johns Hopkins University · UH3 · FY2019 · AI

Macronutrients and Cardiovascular Risk

$1,462,201
Johns Hopkins University · R01 · FY2002 · HL

Development and assessment of cardiovascular risk biomarkers

$1,459,268
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES

$1,458,709
City Of Hope/Beckman Research Institute · P01 · FY2003 · HL

Saturated Fat and Protein Effects on Atherogenic Dyslipidemia

$1,457,421
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · R01 · FY2011 · HL

Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate

$1,456,501
Steven E Shoelson · Joslin Diabetes Center · U01 · FY2007 · DK

Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate

$1,456,500
Steven E Shoelson · Joslin Diabetes Center · U01 · FY2009 · DK

Macronutrients and Cardiovascular Risk

$1,454,348
Johns Hopkins University · R01 · FY2004 · HL

Pathobiology of Macrovascular Disease in Diabetes

$1,453,199
University Of Washington · P01 · FY2002 · DK

BREAD: Basic Mechanisms Underlying Species-Specific Trypanosome Resistance

$1,449,451
Jayne Raper · New York University Medical Center · · FY2010 · BIO

Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease

$1,447,817
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL

Development of recombinant Lecithin Cholesterol Acyltransferase as a therapeutic

$1,447,817
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL

Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate

$1,444,495
Donna K. Arnett · University Of Alabama At Birmingham · R01 · FY2015 · HL

Development Of New Chemotherapeutics For Tuberculosis

$1,444,144
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

The Mechanisms of Alterations in Sleep with Age

$1,443,484
Allan Ian Pack · University Of Pennsylvania · P01 · FY2008 · AG